Pierre Monsan
7Patents
3h-index
16Co-inventors
50Inventor score
Filing activity: Mar 18, 2002 → Feb 13, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7524645B2 | Fully active alternansucrases partially deleted in its carboxy-terminal and amino-terminal domains and mutants thereof | Chemistry; Metallurgy | 12 | Expired |
| US7439049B2 | Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with α 1,2 osidic sidechains | Human Necessities | 7 | Expired |
| US7618951B2 | Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes | Human Necessities | 3 | Expired |
| US9957488B2 | Pharmaceutical compositions and dermatogic compositions synthesized from catalytic domains producing highly α1,2 branched dextrans | Human Necessities | 0 | Active |
| US7846874B2 | Method for the identification of a metabolic pathway family by means of positive selection | Chemistry; Metallurgy | 0 | Expired |
| US9688968B2 | Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly alpha-1,2 branched dextran | Human Necessities | 0 | Active |
| US8758744B2 | Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly α-1,2 branched dextran | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.